drugset / Trial / NCT06977438

GLP-1 Plus Lifestyle for Overall Wellness: Find Your Way Forward

NCT06977438

RandomizedSingle-groupTriple-blindTreatment

Summary

The rapid emergence of new and highly effective obesity medications has turned the field of pediatric weight management on its head. Adolescents living with obesity, their caregivers, healthcare providers, healthcare systems, policymakers, and payors are now wondering what role health behavior and lifestyle treatment (HBLT) has in terms of body mass index (BMI) reduction, improvements in quality of life and cardiometabolic health, and mitigating nutritional concerns when medications are used. Is intensive HBLT needed or could low intensity HBLT be an equally effective alternative; and if so, for whom? Our proposed project will answer these important questions that arise daily in the clinical setting and will generate critical new insights to guide decision-making for teens with obesity and the stakeholders who care deeply about them.

Timeline

Start
2026-10-01
Primary completion
2031-01-31
Completion
2032-01-31

Drugs

EvaluationDrugModalityDoseRoute
Subject Semaglutide Peptide

Indications